BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li H, Wang C, Ma P, Zhang M, Yang H, Yuan S, Wei J, Tao L, Qian K, Xu M, Li L. The retinoid derivant ECPIRM selectively exhibited anti-proliferation effects in cutaneous T-Cell lymphoma via ITK-mediated signaling pathway. J Dermatol Sci 2020;97:208-15. [PMID: 32165081 DOI: 10.1016/j.jdermsci.2020.01.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Lechner KS, Neurath MF, Weigmann B. Role of the IL-2 inducible tyrosine kinase ITK and its inhibitors in disease pathogenesis. J Mol Med (Berl) 2020;98:1385-95. [PMID: 32808093 DOI: 10.1007/s00109-020-01958-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
2 Bresin A, Caprini E, Russo G, Narducci MG. Challenging Cutaneous T-Cell Lymphoma: What Animal Models Tell us So Far. J Invest Dermatol 2022:S0022-202X(21)02615-4. [PMID: 35000751 DOI: 10.1016/j.jid.2021.12.007] [Reference Citation Analysis]
3 Weeks S, Harris R, Karimi M. Targeting ITK signaling for T cell-mediated diseases. iScience 2021;24:102842. [PMID: 34368657 DOI: 10.1016/j.isci.2021.102842] [Reference Citation Analysis]